Moonrise Medical
Medical technology company developing an AI-enabled vascular ultrasound platform designed to automate complex Doppler assessments and Pedal Acceleration Time measurements, making sophisticated vascular imaging easier to perform across more care settings.
INDUSTRY
Medical Devices, Vascular Imaging
SECTOR
MedTech / Vascular Diagnostics / Diagnostic Imaging
FOCUS
Peripheral Artery Disease, Limb Preservation, Point-of-Care Diagnostics
TECHNOLOGY
AI-Enabled Doppler Ultrasound Automation, Pedal Acceleration Time
STAGE OF INVESTMENT
Seed
HEADQUARTERS
Hamilton, Ontario, Canada
WEBSITE
Vascular ultrasound can provide incredibly valuable information, but its dependence on specialized expertise limits where it can be used. Moonrise is building technology that puts more of that expertise into the software, with the potential to bring sophisticated vascular assessment to far more patients.
Douglas Sylvester, JD, LLM
Fund Manager
What they do.
Moonrise Medical is developing an AI-enabled vascular ultrasound platform designed to make complex blood-flow assessments easier to perform at the point of care. Its technology guides users through vessel localization and Doppler imaging, then automates measurements such as Pedal Acceleration Time to help deliver more consistent vascular assessments across a wider range of clinical settings, without requiring a specialist at every site.
Why we invested.
What makes Moonrise particularly compelling is that it is building on an already studied clinical measurement rather than starting with an unproven diagnostic concept. Co-founder Jill Sommerset developed Pedal Acceleration Time, which is supported by a growing body of clinical research. Moonrise is building the automation layer around that science, with the potential to make advanced vascular assessment more consistent, accessible, and scalable without requiring an expert vascular sonographer at every site.
Leadership.
Adam Gold
Co-Founder & CEO
Abubaker Khalifa, MD
Co-Founder & COO
Jill Sommerset, RVT, FSVU
Co-Founder & Chief Scientific Officer
